Genmab A/S

Genmab A/S EBIT per Share

The EBIT per Share of Genmab A/S (GMAB.CO) as of Sep 26, 2026 is 2.96 USD. In the previous year, EBIT per Share was 16.81 USD — a change of -82.39% (lower).

EBIT per Share

2.96USD

YoY

-82.39%

Last updated:

EBIT per Share of Genmab A/S is 2026 2.96 USD. EBIT per Share of Genmab A/S was 2025 16.81 USD. It decreases by -82.39% lower compared to the previous year.

The Genmab A/S EBIT per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT per Share
Date
EBIT per Share
Jan 1, 2024
16.81 USD
Jan 1, 2025
2.96 USD
Jan 1, 2026 (e)
16.09 USD
Jan 1, 2027 (e)
21.89 USD
Jan 1, 2028 (e)
31.66 USD
Jan 1, 2029 (e)
31.17 USD
Jan 1, 2030 (e)
31.77 USD
Jan 1, 2031 (e)
0.00 USD
The Genmab A/S EBIT per Share history
YEAREBIT per ShareYoY
est0.00USD-100.00%
est31.77USD+1.93%
est31.17USD-1.53%
est31.66USD+44.61%
est21.89USD+36.08%
est16.09USD+443.42%
2.96USD-82.39%
16.81USD+36.13%
12.35USD-15.57%
14.63USD+110.98%
6.93USD-53.37%
14.87USD+135.26%
6.32USD+82.99%
3.45USD+5.63%
3.27USD+21.33%
2.69USD+41.63%
1.90USD+165.03%
0.72USD+260.76%
0.20USD-153.05%
-0.38USD-55.99%
-0.85USD+55.44%
-0.55USD-67.73%
-1.70USD-4.73%
-1.78USD+64.00%
-1.09USD-7.43%
-1.17USD—
Access this data via the Eulerpool API
Get Free API Key

Genmab A/S Stock analysis

What does Genmab A/S do? Genmab A/S is a Danish biotechnology company specializing in the discovery and development of antibody therapies for cancer and other serious diseases. The company was founded in 1999 and is headquartered in Copenhagen, Denmark. Genmab A/S is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Genmab A/S stock

EBIT per Share of Genmab A/S is 2.96 USD in 2026.

EBIT per Share of Genmab A/S changed from 16.81 USD to 2.96 USD, representing a -82.39% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBIT per Share Genmab A/S since 2006 – with annual values, charts, and detailed analysis.

EBIT per Share measures operating profit allocated to each outstanding share.

Access this data via the Eulerpool API
Get Free API Key

Income Statement — Genmab A/S

RevenueGross ProfitEBITEBITDANet IncomeEPSCost of Goods SoldR&D ExpensesSG&A ExpensesOperating ExpensesInterest ExpensePretax IncomeTax ExpenseDepreciation & AmortizationRevenue per ShareEBIT per ShareDiluted EPSEBITDA per ShareOther Income/Expense

All Key Metrics — Genmab A/S